Latest Restructuring News

AUCyber Limited reveals a challenging half-year with a $1.6 million EBITDA loss on $12.2 million revenue, alongside operational setbacks and a rejected takeover bid from 5GN Networks.

Cardno Limited has requested an immediate suspension from ASX quotation to facilitate its removal from the official ASX list, marking a significant step in its delisting process.

Advance ZincTek reports steady profit before tax for H1 FY25, driven by strong North American growth and significant cost savings following its Perth facility closure.

Vonex Limited has vested performance rights for its CEO and directors following MaxoTel’s acquisition of majority control, with shares set to be sold on-market. The company reports a mixed 1H FY25 financial performance and is exploring options to repay a $23 million debt facility, including a potential capital raise.

Centrex Limited has initiated a $10.4 million entitlement offer to fund essential plant upgrades and strengthen working capital, following a strategic logistics debt restructuring. The raise is pivotal for advancing the Ardmore phosphate project and maintaining financial viability.

EQ Resources announces a strategic leadership reshuffle, transitioning CEO Kevin MacNeill to CTO to sharpen operational focus and support ambitious growth plans across Australia and Spain.

Bougainville Copper Limited has appointed Johnny Patterson Auna as its permanent CEO, marking a key leadership milestone as the company prepares to ramp up operations at the Panguna mine project.

DomaCom Limited has announced a $1.5 million placement to Lumiere Lifestyle Group, alongside the launch of three innovative funds targeting care and disability accommodation sectors, reinforcing its growth strategy and financial position.

True North Copper Limited (ASX: TNC) has been reinstated to trading following the appointment of voluntary administrators, signaling a critical juncture for the copper miner’s future.

True North Copper has successfully completed a $53.44 million capital raising and debt restructuring, exiting voluntary administration and securing ASX reinstatement. The company shifts focus to exploration at Mt Oxide and Cloncurry, retracting prior production plans for the next 12 months.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.